Technology

TELUS Health enables health data interoperability in Nova Scotia

Published

2 years ago

July 4, 2024

First large-scale initiative in Canada to standardize and connect primary care data for better health outcomes

HALIFAX, NS, July 4, 2024 /CNW/ – Today, TELUS Health announced a collaboration with Nova Scotia Health (NSH) to enable residents of Nova Scotia to access their primary care information through the YourHealthNS app. This health data interoperability initiative marks the first large-scale effort in Canada to standardize and connect primary care data and empowers people in Nova Scotia to better manage their health and improve health outcomes.

“TELUS Health is very proud to be collaborating with Nova Scotia Health to support primary care data access for all Nova Scotians,” said Martin Bélanger, Senior Vice-president, Payor & Provider Solutions, TELUS Health. “We have been working on various opportunities across Canada to support, enable and advance data interoperability, responding to the growing demand from Canadians. Our collective efforts in Nova Scotia show that with provincial leadership and support, swift action and a patient-first approach, we can advance digital healthcare innovation to address the unique needs and priorities of specific regions.”

TELUS Health is a leader in digital health data and currently supports most of Nova Scotia’s clinicians with electronic medical records (EMRs) to enhance their practice and patient care. Through this collaboration, TELUS Health is using its integrated data platform to extract relevant patient summary data from these EMRs.

“The collaboration between TELUS Health and Nova Scotia Health has been a significant and positive factor contributing to the success of our journey to do more and go faster,” said Scott McKenna, Chief Information Officer, Nova Scotia Health. “Nova Scotia is proud to lead the way in creating the partnerships and digital foundations necessary to empower citizens and advance the Pan-Canadian Interoperability Roadmap.”

Providing patients with seamless and secure access to their health information benefits not only the patients themselves but also clinicians and care providers. This access leads to greater efficiencies, supports effective communication and ultimately enhances the overall patient experience, as demonstrated by a pilot project launched in early 2024. Among the 13,000 participants, 68 per cent who accessed their health records reported their patient experience as good or excellent.

As the f irst company in the world to achieve the ISO 31700-1 Privacy by Design certification, TELUS Health is committed to safeguarding privacy and advancing the principles of trustworthy data practices across Canada and beyond. TELUS Health aligns with the Government of Nova Scotia’s dedication to using healthcare data solely for the advancement of healthcare, ensuring that individuals can lead healthier lives.

TELUS Health looks forward to collaborating with other provinces across the country to replicate this success.

About TELUS Health
TELUS Health is on a mission to become the most trusted wellbeing company in the world by enhancing the overall efficiency of healthcare and championing workplace wellbeing. By integrating advanced healthcare technology with comprehensive employee support services, TELUS Health provides a holistic approach to primary and preventive health and wellbeing for 72 million people across 160 countries. Our innovative digital health platforms, including electronic medical records (EMRs) and virtual care solutions, empower healthcare professionals, individuals, employers and governments to deliver personalized care efficiently. Our employee wellbeing programs offer extensive support through Employee Assistance Programs (EAPs), mental health resources, financial counseling, and workplace wellness initiatives. At TELUS Health, we are committed to revolutionizing healthcare to ensure people receive the support they need and employees thrive both personally and professionally. Together, let’s make the future friendly. For more information, visit: www.telushealth.com.

Media Contact:

Jill Yetman
TELUS Health
jill.yetman@telus.com

SOURCE TELUS Health

Technology

IGCS International Announces Strategic Equity Investment by Lacks Enterprises

Published

51 minutes ago

April 22, 2026

DALLAS, April 22, 2026 /PRNewswire/ — IGCS International, a CVE-certified SDVOSB and leading provider of mission support and MRO supplies to the U.S. Department of Defense and federal agencies, today announced that Lacks Enterprises has acquired an equity stake in the company.

The strategic investment combines IGCS’s expertise in government supply chain, logistics, and MRO solutions with Lacks Enterprises’ advanced manufacturing capabilities, including electroplating, injection molding, composites, and testing for aerospace and defense.

“IGCS has built a strong track record supporting the Department of Defense… Partnering with Lacks Enterprises allows us to integrate cutting-edge manufacturing innovation into our offerings,” said Russ Spears, President of IGCS International.

Media Contact: Russ Spears, 214-733-7278, russ@igcsintl.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/igcs-international-announces-strategic-equity-investment-by-lacks-enterprises-302750824.html

SOURCE IGCS International

Technology

Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026

Published

51 minutes ago

April 22, 2026

GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (“Shoulder Innovations”) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026.

Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domestic callers or (412) 902-1015 for international callers and providing access code 13759613. A live and archived webcast of the event will be available in the “Investor Relations” section of the Shoulder Innovations website at https://ir.shoulderinnovations.com/.

About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations’ ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations’ ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Contact
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-report-first-quarter-2026-financial-results-on-may-13-2026-302750154.html

SOURCE Shoulder Innovations

Technology

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

Published

51 minutes ago

April 22, 2026

MADISON, Wis., April 22, 2026 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 6, 2026.

The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call’s conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID: 4178502.

A live webcast of the call will also be available from the Investor Relations section of the company’s website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the fourth quarter of fiscal 2026.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor and Media Contact
Steve Monroe
VP, Financial Planning & Analysis, Accuray
Investor.relations@accuray.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-third-quarter-fiscal-2026-financial-results-on-may-6-2026-302750641.html

SOURCE Accuray Incorporated